Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients

AIMS: To evaluate the tolerability of single oral SDZ RAD doses in stable renal transplant recipients and the pharmacokinetics of ascending SDZ RAD doses when coadministered with steady-state cyclosporin A microemulsion (Neoral). METHODS: This randomized, double-blind, placebo-controlled, sequential...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Neumayer, H-H, Paradis, K, Korn, A, Jean, C, Fritsche, L, Budde, K, Winkler, M, Kliem, V, Pichlmayr, R, Hauser, I A, Burkhardt, K, Lison, A-E, Barndt, I, Appel-Dingemanse, S
Format: Artigo
Langue:Inglês
Publié: Blackwell Science Inc 1999
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2014362/
https://ncbi.nlm.nih.gov/pubmed/10594471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.1999.00085.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires